在脑粉样血管病变中通过脂质介导形成反平行聚合物
Ana Pacheco de Oliveira1, Divya Baghel1, Brooke Holcombe1
1Department of Chemistry and Biochemistry, The University of Alabama, Tuscaloosa, AL, 35401, USA.
Acta neuropathologica
|July 13, 2025
概括
大脑粉样蛋白血管病变 (CAA) 涉及大脑血管中的粉样蛋白-β (Aβ) 积累. 这项研究揭示了与CAA严重程度的Aβ沉积物中的反平行β片结构的增加,与脂质和潜在的神经毒性有关.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 医疗成像医学成像
背景情况:
- 大脑粉样蛋白血管病 (CAA) 是一种大脑血管疾病,其特点是大脑血管中的粉样蛋白-β (Aβ) 沉积,通常导致出血和中风.
- 虽然与阿尔茨海默病 (AD) 共享粉样β病理,但CAA中Aβ的精确结构形式和化学关联仍然不清楚.
- 现有的方法可能错过了血管粉样蛋白聚合物的异质性和多态性.
研究的目的:
- 研究CAA不同阶段的人类大脑组织中血管粉样聚合物的化学结构和异质性.
- 阐明粉样β (Aβ) 沉积物的结构变化及其与疾病进展和同局部化分子的关系.
主要方法:
- 利用分衍射,无标签的光学光热红外光谱成像 (O-PTIR) 来直接在人脑组织中分析血管粉样蛋白聚合物.
- 采用纳米级AFM-IR光谱来验证ex-vivo发现,并研究体内Aβ与脂质的聚合.
- 检查了与疾病严重程度和脂质同局部化相关的粉样蛋白β (Aβ) 结构分布.
主要成果:
- 在血管Aβ沉积物中的β-片含量逐渐增加,与CAA严重程度相关.
- 发现了大量的反平行β片结构,特别是在中度至重度的CAA病例中.
- 观察到抗平行Aβ结构和同局部脂质之间存在强烈的相关性,这表明一种脂质介导的聚合机制.
结论:
- 该研究揭示了大脑粉样蛋白血管病变 (CAA) 中粉样蛋白β (Aβ) 的明显结构多态,包括与疾病严重程度相增加的反平行β片.
- 脂质与反平行Aβ结构的共同定位表明CAA中的脂质驱动的聚合途径.
- 这些发现为CAA中的Aβ聚合结构提供了关键的见解,有可能解释传统纤维细胞模型之外的其他神经毒性机制.
相关概念视频
Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


